AGT-189

N/A

Report date: 2022/03/30 10:27:04

Base Information

Drug NameAGT-189

Drug Alias NameHIRMAb-ASMAGT-189

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionSphingomyelinase replacementsInsulin receptor agonists

TargetsSphingomyelinInsulin receptor

Therapy Area/IndicationsNiemann-Pick Disease, Type A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArmagen Inc

China Registration ClassN/A

Active CompaniesArmagen Inc

Inactive CompaniesN/A

Active IndicationsNiemann-Pick Disease, Type A

Inactive IndicationsN/A

ATC CodeN/A